Concepedia

Publication | Closed Access

Nivolumab Plus Low-Dose IPILIMUMAB as First-Line Treatment of Advanced NSCLC: Overall Survival Analysis of Checkmate 817

DOI

17

Citations

0

References

2019

Year

Fabrice Barlési, Clarisse Audigier-Valette, Enriqueta Felip, T-E. Ciuleanu, Kevin Jao, Erika Rijavec, László Urbán, Jean-Sebastien Aucoin, Cristina Zannori, Karim Vermaelen,
Annals of Oncology

No additional data available for this publication yet. Check back later!